Opening book details…
About this Medicine article
P0815 : Cost-effectiveness of treating different stages of genotype 1 hepatitis C Virus (HCV) with AbbVie 3D (ABT-450/ritonavir/ombitasvir and dasabuvir) +/− ribavirin compared to no treatment in the United States by Johnson, S.J.; Misurski, D.A.; Juday, T.R.; Samp, J.C.; Marx, S.E.; Parisé, H.; Virabhak, S.; Saab, S. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Johnson, S.J.; Misurski, D.A.; Juday, T.R.; Samp, J.C.; Marx, S.E.; Parisé, H.; Virabhak, S.; Saab, S.
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV; Wiley (ISSN 0168-8278)
- Published
- 2015
- Field
- Medicine (Health Sciences)